Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling (Q39699823)

14 September 2017

title

Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling (English)

1 reference

14 September 2017

0 references

1 reference

S Drewlo

1

1 reference

14 September 2017

K Levytska

2

1 reference

14 September 2017

M Sobel

3

1 reference

14 September 2017

D Baczyk

4

1 reference

14 September 2017

S J Lye

5

1 reference

14 September 2017

J C P Kingdom

6

1 reference

14 September 2017

publication date

1 December 2011

1 reference

Journal of Thrombosis and Haemostasis

14 September 2017

published in

1 reference

14 September 2017

volume

9

1 reference

14 September 2017

issue

12

1 reference

14 September 2017

page(s)

2486-2497

1 reference

Latest advances in understanding preeclampsia

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

The frequency and severity of placental findings in women with preeclampsia are gestational age dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Non-anticoagulant heparins and inhibition of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Promotion of trophoblast stem cell proliferation by FGF4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Heparin prevents programmed cell death in human trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Effect of heparin and fractionated heparin on trophoblast invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Apoptosis and its role in the trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Promotion of angiogenesis by human endometrial lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

The "Great Obstetrical Syndromes" are associated with disorders of deep placentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Local guidance of emerging vessel sprouts requires soluble Flt-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Use of low molecular weight heparin in pregnant women with mechanical heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04526.X

10.1111/J.1538-7836.2011.04526.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference